These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 36813396)
1. Topical Ocular Therapeutics in Small Animals. James-Jenks EM; Pinard CL Vet Clin North Am Small Anim Pract; 2023 Mar; 53(2):473-492. PubMed ID: 36813396 [TBL] [Abstract][Full Text] [Related]
2. Effects of common topical antiglaucoma medications on the ocular surface, eyelids and periorbital tissue. Servat JJ; Bernardino CR Drugs Aging; 2011 Apr; 28(4):267-82. PubMed ID: 21428462 [TBL] [Abstract][Full Text] [Related]
3. Ocular therapeutics. Moore CP Vet Clin North Am Small Anim Pract; 2004 May; 34(3):XI-XII. PubMed ID: 15110987 [No Abstract] [Full Text] [Related]
4. Control of ocular inflammation. Wilkie DA Vet Clin North Am Small Anim Pract; 1990 May; 20(3):693-713. PubMed ID: 2194354 [TBL] [Abstract][Full Text] [Related]
5. Factors influencing the penetration of therapeutic substances into the eye following topical application. Piercy DW Vet Rec; 1985 Jan; 116(4):99-104. PubMed ID: 3883638 [No Abstract] [Full Text] [Related]
6. Topical nonsteroidal anti-inflammatory drugs for ophthalmic use: a safety review. Gaynes BI; Fiscella R Drug Saf; 2002; 25(4):233-50. PubMed ID: 11994027 [TBL] [Abstract][Full Text] [Related]
7. Veterinary ophthalmic pharmacology and therapeutics. 2. Topical anesthetics. Gelatt KN Vet Med Small Anim Clin; 1968 Aug; 63(8):751-4. PubMed ID: 5187070 [No Abstract] [Full Text] [Related]
8. Ocular Side Effects of Common Systemic Medications and Systemic Side Effects of Ocular Medications. Syed MF; Rehmani A; Yang M Med Clin North Am; 2021 May; 105(3):425-444. PubMed ID: 33926639 [TBL] [Abstract][Full Text] [Related]
9. Systemic toxicity. Associated with topical ophthalmic medications. Flach AJ J Fla Med Assoc; 1994 Apr; 81(4):256-60. PubMed ID: 8046365 [TBL] [Abstract][Full Text] [Related]
10. A Cross-sectional Online Questionnaire-based Survey About the Use of Compounded Medications in Veterinary Ophthalmology. Andrade F; Saldanha A; Bastos JT; Montiani-Ferreira F Int J Pharm Compd; 2024; 28(3):214-225. PubMed ID: 38768503 [TBL] [Abstract][Full Text] [Related]
11. Nonsteroidal anti-inflammatory drugs in veterinary ophthalmology. Giuliano EA Vet Clin North Am Small Anim Pract; 2004 May; 34(3):707-23. PubMed ID: 15110980 [TBL] [Abstract][Full Text] [Related]
12. Topical ophthalmic drugs and the pediatric patient. Chung I; Buhr V Optometry; 2000 Aug; 71(8):511-8. PubMed ID: 15326908 [TBL] [Abstract][Full Text] [Related]
13. Nonhypotensive autonomic agents in veterinary ophthalmology. Klauss G; Constantinescu GM Vet Clin North Am Small Anim Pract; 2004 May; 34(3):777-800. PubMed ID: 15110984 [TBL] [Abstract][Full Text] [Related]
15. Principles of therapeutics. Miller TR Vet Clin North Am Equine Pract; 1992 Dec; 8(3):479-97. PubMed ID: 1458325 [TBL] [Abstract][Full Text] [Related]
16. The use of corticosteroids to treat ocular inflammation. Holmberg BJ; Maggs DJ Vet Clin North Am Small Anim Pract; 2004 May; 34(3):693-705. PubMed ID: 15110979 [TBL] [Abstract][Full Text] [Related]
18. Ocular preparations: the formulation approach. Kaur IP; Kanwar M Drug Dev Ind Pharm; 2002 May; 28(5):473-93. PubMed ID: 12098838 [TBL] [Abstract][Full Text] [Related]
19. Locally administered ocular corticosteroids: benefits and risks. McGhee CN; Dean S; Danesh-Meyer H Drug Saf; 2002; 25(1):33-55. PubMed ID: 11820911 [TBL] [Abstract][Full Text] [Related]
20. Advancements in ocular drug delivery. Weiner AL; Gilger BC Vet Ophthalmol; 2010 Nov; 13(6):395-406. PubMed ID: 21182726 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]